Cosmetic Peptide COA Checklist for Bulk Raw Materials

Match the certificate to the physical lot

Confirm supplier legal name, manufacturing site where relevant, product code, INCI, lot number, manufacture or retest date, quantity and container count. Compare them with the label and purchase order. A COA issued for a parent lot may not describe a repacked sub-lot unless traceability is documented. Reject certificates that can be reused across shipments because they carry no lot-specific identifier.

Read identity before purity

The certificate should show how identity was established: mass spectrometry, retention-time comparison, amino-acid analysis or another justified method. HPLC area purity alone cannot identify a peptide. Similar INCI names and short sequences are easy to confuse in purchasing systems. For salt, acetate or hydrated forms, ensure the reported molecular basis matches the material used in formula calculations.

Ask what the assay percentage actually measures

Purity, peptide content and active content are not synonyms. Area percent may exclude water, counterions and non-UV-absorbing carriers. A stock solution requires a weight-percent or otherwise defined active assay plus complete composition. Record whether the result is as-is, anhydrous, dry basis or calculated. If the supplier cannot explain the denominator, the procurement team cannot compare lots or vendors.

Review impurities according to process risk

Relevant fields may include residual solvents, water, related peptides, free amino acids, counterions, heavy metals and synthesis reagents. The list should follow the manufacturing route and destination-market needs rather than a generic template. A pass result with a reporting limit above the specification is not a pass. Check units carefully; ppm, micrograms per gram and percent errors survive surprisingly often in copied certificates.

Stock solutions need microbiology and preservative disclosure

For water-based peptide solutions, require microbial limits and the declared preservative system. pH, appearance, odor and density help confirm consistency. A supplier statement that the peptide is self-preserving is not enough without supporting data. The raw-material microbiological result also does not replace challenge testing of the finished serum, where dilution and other ingredients change preservative performance.

Interrogate third-party reports without treating them as magic

Check laboratory accreditation scope, sample description, chain of custody, test method, detection limits, dates and authorized signature. A third-party logo does not prove the sample came from your lot. Cropped chromatograms and identical peak tables across different batches are warning signs. For critical materials, send a sealed sample selected by your team to an independent laboratory and compare the result with the supplier's certificate.

Create a three-way reconciliation

Place the purchase specification, supplier COA and your incoming results side by side. Every release parameter should use compatible units and methods. Investigate unexplained rounding, changed test names or a result that equals the limit on every lot. Trend pH, assay, water and key impurities over time; drift may reveal process change before a lot formally fails.

Control revisions and supplier changes

Approve the specification version before ordering and require notice for changes in synthesis route, site, carrier, preservative, analytical method or packaging. Keep signed COAs and raw-data requests with the lot record. A new supplier using the same INCI is not automatically equivalent. Run sample qualification and formula compatibility before switching commercial production.

A five-minute desk review before laboratory work

Begin with three marks on the COA. Circle the exact material and lot, underline every result unit, and box the method or method reference. If any of those items are absent, stop and request correction before arranging expensive testing. Next, compare the specification limits with the signed purchase specification; supplier limits sometimes widen without notice. Recalculate one percentage or conversion independently, especially for active stock solutions. Check whether the manufacture, test, approval and retest dates form a plausible sequence. Search the file properties or visual artifacts only as supporting clues, never as proof of fraud. Then choose confirmation tests according to risk: identity for a new source, assay for a claim-critical active, microbiology for aqueous stock, or residuals where process history warrants it. Document why each test was selected. This short review catches many administrative failures while preserving laboratory budget for questions that analytical work can actually answer.

Questions buyers also ask

What should a peptide COA include?

At minimum: exact material and lot identity, relevant test methods, specifications, lot results, units, dates and authorization, plus active-basis clarity.

Is 98% HPLC purity enough to approve a peptide?

No. It does not by itself establish identity, weight-percent assay, carrier composition, microbiology or suitability in the finished formula.

How can a buyer spot a questionable COA?

Look for missing lot identifiers, undefined percentages, absent methods, inconsistent units, recycled chromatograms and reports that do not identify the tested sample.